» Articles » PMID: 20405335

Time to Depression Treatment in Primary Care Among HIV-infected and Uninfected Veterans

Overview
Publisher Springer
Specialty General Medicine
Date 2010 Apr 21
PMID 20405335
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Multiple factors, including patient characteristics, competing demands, and clinic type, impact delivery of depression treatment in primary care.

Objective: Assess whether depression severity and HIV serostatus have a differential effect on time to depression treatment among depressed patients receiving primary care at Infectious Disease or General Medicine clinics.

Design: Multicenter prospective cohort, (Veterans Aging Cohort Study), comparing HIV-infected to uninfected patients.

Participants And Measures: The total cohort consisted of 3,239 HIV-infected and 3,227 uninfected patients. Study inclusion criteria were untreated depressive symptoms, based on a Patient Health Questionnaire (PHQ-9) score of greater than 9, and no antidepressants or mental health visits in the 90 days prior to PHQ-9 assessment. Treatment was defined as antidepressant receipt or mental health visit within 90 days following PHQ-9 assessment. Depression severity based on PHQ-9 scores was defined as mild-moderate (greater than 9 to 19) and severe (20 or greater). Kaplan-Meier curves were used to estimate time to treatment by depression severity and HIV serostatus. Cox proportional hazards methods adjusted for covariates were used.

Key Results: Overall, 718 (11%) of the cohort met inclusion criteria, 258 (36%) of whom received treatment. Median time to treatment was 7 days [95% confidence interval (CI) = 4, 13] and was shortest for severely depressed HIV-infected patients (0.5 days; 95% CI = 0.5, 6, p = 0.04). Compared to mildly-moderately depressed uninfected patients, severely depressed HIV-infected patients were significantly more likely to receive treatment [adjusted hazard ratio (HR) 1.67, 95% CI = 1.07, 2.60), whereas mildly-moderately depressed HIV-infected patients (adjusted HR 1.10, 95% CI = 0.79, 1.52) and severely depressed uninfected patients (adjusted HR 0.93, 95% CI = 0.60, 1.44) were not.

Conclusions: In this large cohort, time to primary care treatment of depression was shortest among severely depressed HIV-infected patients. Regardless of HIV serostatus, if depression was not treated on the assessment day, then it was unlikely to be treated within a 90-day period, leading to the majority of depression being untreated.

Citing Articles

Risk factors for suicide among veterans living with and without HIV: a nested case-control study.

Smith A, Goulet J, Vlahov D, Justice A, Womack J AIDS Behav. 2023; 28(1):115-124.

PMID: 37751112 PMC: 11289766. DOI: 10.1007/s10461-023-04164-3.


Racial Differences in Change in Physical Functioning in Older Male Veterans with HIV.

McKellar M, Kuchibhatla M, Oursler K, Crystal S, Akgun K, Crothers K AIDS Res Hum Retroviruses. 2019; 35(11-12):1034-1043.

PMID: 30963773 PMC: 6862951. DOI: 10.1089/AID.2018.0296.


HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities.

Tedaldi E, Minniti N, Fischer T Biomed Res Int. 2015; 2015:641913.

PMID: 25815329 PMC: 4359826. DOI: 10.1155/2015/641913.


Factors associated with treatment initiation for psychiatric and substance use disorders among persons with HIV.

Satre D, DeLorenze G, Quesenberry C, Tsai A, Weisner C Psychiatr Serv. 2013; 64(8):745-53.

PMID: 23584606 PMC: 4030718. DOI: 10.1176/appi.ps.201200064.


Agreement between electronic medical record-based and self-administered pain numeric rating scale: clinical and research implications.

Goulet J, Brandt C, Crystal S, Fiellin D, Gibert C, Gordon A Med Care. 2012; 51(3):245-50.

PMID: 23222528 PMC: 3572341. DOI: 10.1097/MLR.0b013e318277f1ad.


References
1.
Himelhoch S, Medoff D . Efficacy of antidepressant medication among HIV-positive individuals with depression: a systematic review and meta-analysis. AIDS Patient Care STDS. 2005; 19(12):813-22. DOI: 10.1089/apc.2005.19.813. View

2.
Treisman G, Angelino A . Interrelation between psychiatric disorders and the prevention and treatment of HIV infection. Clin Infect Dis. 2008; 45 Suppl 4:S313-7. DOI: 10.1086/522556. View

3.
Block S . Assessing and managing depression in the terminally ill patient. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians - American Society of Internal Medicine. Ann Intern Med. 2000; 132(3):209-18. DOI: 10.7326/0003-4819-132-3-200002010-00007. View

4.
Justice A, Dombrowski E, Conigliaro J, Fultz S, Gibson D, Madenwald T . Veterans Aging Cohort Study (VACS): Overview and description. Med Care. 2006; 44(8 Suppl 2):S13-24. PMC: 3049942. DOI: 10.1097/01.mlr.0000223741.02074.66. View

5.
Wulsin L, Vaillant G, Wells V . A systematic review of the mortality of depression. Psychosom Med. 1999; 61(1):6-17. DOI: 10.1097/00006842-199901000-00003. View